NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

The old trademark, Serial No. 76029211, was registered on 10/15/2002. It was registered under Good & Services: Vaccines.

The new trademark was registered under Goods & Services: Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Medical preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators; Derivatives and modulators of immune cells, namely, vaccines, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for medical or veterinary use; Vaccines.

The new trademark is a lot more detailed, comprehensive and expansive. NWBO is preparing for global marketing of its DCVax platform, and is protecting its global brand as it relates to cancer immunotherapy, and immune system modulation.